Target intelligence / Profile preview

Peptidylprolyl isomerase C

Molecular classification
Enzyme, Peptidyl-prolyl cis-trans isomerase, Foldase
01

Overview

Peptidylprolyl isomerase C refers to an enzyme that catalyzes the cis-trans isomerization of peptide bonds at proline residues in polypeptides, a key step in protein folding and regulation of protein function[2][4][5]. These enzymes, collectively known as peptidyl-prolyl cis-trans isomerases (PPIases), are found in all domains of life and fall into three main families: cyclophilins, FK506-binding proteins, and parvulins[5]. Cyclophilin C (PPIC), sometimes called peptidylprolyl isomerase C, is a member of the cyclophilin family and has been implicated in immune regulation because it binds the immunosuppressive drug cyclosporin A[5]. PPIases, including Pin1 and related enzymes, have roles in cell cycle progression, gene regulation, and disease states such as cancer, viral infection, and neurodegeneration[1][5]. The designation "peptidylprolyl isomerase C" is specific but may be ambiguous, as most data and therapeutic targeting efforts focus on distinct isoforms (e.g., Pin1, cyclophilin A/B/C), so caution is warranted in mapping literature references[5].

Other names
PPIase Ccyclophilin CPPIC
02

Mechanism of action

Inhibition by binding to active site (e.g., cyclosporin A inhibits cyclophilins, affecting isomerase activity and downstream pathways)

03

Biological functions

Protein foldingCis-trans proline isomerizationRegulation of protein conformationModulation of immune function
04

Disease associations

CancerNeurodegenerative diseaseInflammationInfection
05

Safety considerations

Immunosuppression (for inhibitors like cyclosporin A)Potential for off-target effects due to ubiquity in protein folding
06

Interacting drugs

Cyclosporin A (for cyclophilins, including related PPIases)
07

Biomarkers

Null (no evidence found for established biomarkers based on current sources)

Beyond the preview

Go deeper on Peptidylprolyl isomerase C.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidylprolyl isomerase C.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call